What branch does mammary gland hyperplasia see

Update Date: Source: Network

summary

Hyperplasia of mammary glands is a common disease among women. The age of onset is 18~35 years old, and the incidence rate is 58% to 89% of women. The incidence rate of city is higher than that of rural area. Therefore, we need to know more about breast hyperplasia.

What branch does mammary gland hyperplasia see

First: breast hyperplasia to see the breast. Infrared thermography examination: it is based on the characteristics of infrared radiation in normal human body and breast cancer tissue with rapid increment, exuberant metabolism and rich blood, which can produce stronger infrared radiation than the surrounding normal tissue. The infrared thermography technology is used to change the temperature difference on the surface of the breast into an image visible to the naked eye.

Second: multiple fine-needle aspiration cytology: it is of great value in the diagnosis of epithelial hyperplasia. Combined with X-ray fluoroscopy guided puncture biopsy, the diagnostic accuracy is very good, but for suspected cases of canceration, the final diagnosis depends on tissue sections.

Third: B-mode ultrasound: the accuracy rate of diagnosis of breast masses is about 90%. Ultrasound shows that there is no uniform hypoechoic area and anechoic cyst in the hyperplasia site. B-mode ultrasound is very convenient and noninvasive for follow-up of breast hyperplasia. Because of the great difference of detection technology, it should be combined with clinical diagnosis.

matters needing attention

Iodine in food containing iodine can promote luteinization of ovarian follicles, reduce the level of estrogen in the body and eliminate the hidden danger of hyperplasia of mammary glands. Kelp contains a lot of iodine, kelp also has the function of soft and hard, eliminating pain and reducing mass. Patients with hyperplasia of mammary glands should eat kelp 1 to 2 times a week, such as cold shredded kelp, spareribs and soybean stewed kelp, which is also a therapeutic measure for hyperplasia of mammary glands.